| Quarterly Financials | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 1,566 | 1,576 | 1,918 | 1,839 | 1,797 | 1,853 | 2,156 | 2,209 | 2,032 | 2,091 | 2,326 | 2,307 | 1,768 | 2,252 | 2,234 | 2,421 | 2,381 | 2,515 | 2,662 | 2,750 | 2,699 | 2,835 | 3,202 | 956 | 849 | 933 | 1,108 | 978 | 6,122 | 1,122 | 1,083 | 1,032 | 1,111 | 1,226 | 1,214 |
| Expenses | 1,517 | 1,428 | 1,643 | 1,521 | 1,651 | 1,714 | 1,891 | 1,851 | 1,806 | 1,842 | 1,955 | 1,878 | 1,618 | 1,972 | 1,900 | 2,070 | 2,091 | 2,162 | 2,253 | 2,267 | 2,370 | 2,498 | 2,744 | 687 | 747 | 856 | 806 | 861 | 841 | 869 | 888 | 845 | 881 | 962 | 1,012 |
| EBITDA | 49 | 148 | 276 | 318 | 146 | 139 | 265 | 358 | 226 | 249 | 371 | 429 | 150 | 280 | 335 | 351 | 290 | 353 | 409 | 482 | 329 | 337 | 458 | 269 | 102 | 78 | 302 | 117 | 5,281 | 252 | 195 | 187 | 230 | 264 | 202 |
| Operating Profit % | 3 % | 9 % | 9 % | 15 % | 7 % | 7 % | 12 % | 16 % | 11 % | 12 % | 16 % | 18 % | 8 % | 12 % | 15 % | 13 % | 12 % | 14 % | 15 % | 17 % | 11 % | 11 % | 14 % | 15 % | 11 % | 8 % | 16 % | 12 % | 16 % | 20 % | 15 % | 16 % | 18 % | 20 % | 15 % |
| Depreciation | 79 | 95 | 68 | 56 | 74 | 76 | 79 | 78 | 126 | 149 | 140 | 171 | 155 | 153 | 157 | 153 | 153 | 156 | 161 | 170 | 175 | 189 | 198 | 54 | 51 | 54 | 57 | 58 | 60 | 62 | 62 | 64 | 63 | 66 | 68 |
| Interest | 43 | 46 | 49 | 47 | 40 | 40 | 56 | 55 | 88 | 88 | 72 | 112 | 80 | 75 | 62 | 77 | 67 | 61 | 67 | 62 | 69 | 77 | 87 | 25 | 25 | 30 | 25 | 30 | 29 | 32 | 31 | 32 | 31 | 31 | 32 |
| Profit Before Tax | -73 | 7 | 158 | 216 | 32 | 24 | 130 | 224 | 12 | 12 | 160 | 146 | -85 | 53 | 115 | 122 | 71 | 135 | 181 | 250 | 85 | 71 | 173 | 190 | 26 | -7 | 221 | 28 | 5,191 | 159 | 102 | 91 | 136 | 167 | 103 |
| Tax | 7 | 9 | -1 | 10 | 12 | 10 | 17 | 4 | 2 | 5 | 8 | -0 | 4 | 10 | 8 | 5 | 11 | 8 | 13 | 4 | 6 | 17 | 14 | 7 | 6 | 8 | 11 | 31 | 39 | 53 | 38 | 5 | 43 | 46 | 44 |
| Net Profit | -80 | -3 | 159 | 205 | 20 | 14 | 113 | 220 | 10 | 7 | 151 | 146 | -89 | 42 | 107 | 117 | 60 | 128 | 168 | 246 | 80 | 54 | 159 | 183 | 20 | -15 | 209 | -2 | 5,152 | 106 | 64 | 86 | 94 | 121 | 59 |
| EPS in ₹ | -1.66 | 0.01 | 3.33 | 4.07 | 0.25 | 0.22 | 2.00 | 4.10 | 0.06 | 0.06 | 2.78 | 2.61 | -1.67 | 0.66 | 1.86 | 2.12 | 0.89 | 2.15 | 2.98 | 4.55 | 1.38 | 0.93 | 2.80 | 3.43 | 0.10 | -0.62 | 3.60 | -0.48 | 103.34 | 1.94 | 1.14 | 1.59 | 1.67 | 2.13 | 1.02 |
Aster DM Healthcare
Aster DM Healthcare
684.45
+4.70
(0.69%)
Market Cap
35,462.79 Cr
PE Ratio
98.17
Volume
5,37,566.00
Day High - Low
685.90 - 673.25
52W High-Low
732.20 - 492.20
Key Fundamentals
Market Cap
35,462.79 Cr
EPS
107.98
PE Ratio
98.17
PB Ratio
8.42
Book Value
80.76
EBITDA
912.80
Dividend Yield
0.71 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
9.22
Debt to Equity
0.47
Analyst Rating and Forecast
- By Refinitiv from10 analysts
Actual
Company News
View All News
HSBC Raises Aster DM Target to ₹755 on Strong Outlook1 day ago
HSBC upgrades Aster DM Healthcare target price to ₹755 from ₹635, maintaining Buy rating on expectations of steady Q4FY26 performance with elective procedure recovery and continued expansion.
Aster DM Healthcare announces successful completion of postal ballot with 91.63% voter turnout. Both special resolutions passed with requisite majority including appointment of Dr. Mandayapurath Azad Moopen as Executive Director.
Aster DM Healthcare announces full resumption of Kerala hospital operations after nurses returned to duty, with additional revenue loss of ₹5.77 crore disclosed due to strike impact.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
7,706.50 | #1 1,10,807.65 | 59.68 | #1 21,994.30 | 14.76 | #1 1,505 | 36.08 | 60.38 | |
1,010.45 | 98,330.43 | 70.06 | 7,184.10 | #1 28.68 | 1,076 | 26.01 | 61.35 | |
928.85 | 70,124.29 | 70.56 | 7,849.70 | 13.25 | 809 | -22.38 | 66.89 | |
1,813.20 | 37,054.70 | 47.30 | 5,575.00 | 12.29 | 790 | -34.33 | 59.76 | |
684.45 | #5 35,462.79 | #10 98.17 | #5 4,286.70 | #5 15.12 | #7 337 | #6 -8.85 | 55.47 | |
1,113.80 | 29,937.87 | 56.61 | 3,771.40 | 12.59 | 481 | -33.52 | 55.41 | |
681.50 | 27,269.47 | 86.53 | 3,067.00 | 21.98 | 415 | -43.89 | 58.31 | |
461.15 | 14,609.58 | 90.25 | 1,757.00 | 27.64 | 110 | #1 54.61 | 63.42 | |
1,296.10 | 13,163.08 | 49.89 | 1,566.90 | 17.46 | 244 | 7.26 | 63.84 | |
230.98 | 9,976.74 | #1 35.91 | 1,426.00 | 12.90 | 213 | 15.54 | 67.66 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
15.12 %
Net Income Growth
64.48 %
Cash Flow Change
169.34 %
ROE
126.54 %
ROCE
87.55 %
EBITDA Margin (Avg.)
31.50 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 6,807 | 7,484 | 8,936 | 12,438 | 11,644 | 12,546 | 14,881 | 17,991 | 6,606 |
| Fixed Assets | 3,520 | 3,738 | 4,289 | 7,124 | 6,749 | 7,009 | 9,052 | 3,175 | 3,920 |
| Current Assets | 2,473 | 2,869 | 3,617 | 4,096 | 3,629 | 4,097 | 4,922 | 14,165 | 1,902 |
| Capital Work in Progress | 290 | 402 | 550 | 736 | 934 | 998 | 279 | 170 | 293 |
| Investments | 32 | 38 | 22 | 34 | 63 | 45 | 80 | 17 | 245 |
| Other Assets | 2,966 | 3,307 | 4,076 | 4,544 | 3,898 | 4,495 | 5,470 | 14,629 | 2,148 |
| Total Equity & Liabilities | 6,807 | 7,484 | 8,936 | 12,438 | 11,644 | 12,546 | 14,881 | 17,991 | 6,606 |
| Current Liabilities | 2,201 | 2,224 | 2,668 | 3,722 | 3,196 | 3,559 | 4,655 | 11,288 | 879 |
| Non Current Liabilities | 2,355 | 2,071 | 2,589 | 4,997 | 4,614 | 4,505 | 5,366 | 1,673 | 2,076 |
| Total Equity | 2,251 | 3,190 | 3,680 | 3,719 | 3,834 | 4,483 | 4,861 | 5,030 | 3,651 |
| Reserve & Surplus | 1,034 | 1,953 | 2,334 | 2,401 | 2,501 | 3,080 | 3,574 | 3,686 | 2,554 |
| Share Capital | 403 | 505 | 505 | 497 | 497 | 500 | 500 | 500 | 500 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 5 | -122 | 61 | 33 | -110 | 120 | 65 | 66 | 332 | 82 |
| Investing Activities | -439 | -775 | -1,136 | -522 | -702 | -658 | -333 | -563 | -951 | -878 | 6,015 |
| Operating Activities | 236 | 203 | 361 | 537 | 601 | 1,223 | 1,569 | 1,314 | 1,834 | 158 | 425 |
| Financing Activities | 203 | 578 | 654 | 46 | 134 | -675 | -1,116 | -686 | -817 | 1,053 | -6,358 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Apr 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.89 % | 40.38 % | 40.39 % | 40.39 % | 40.39 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 33.09 % | 29.09 % | 29.09 % | 40.21 % | 29.09 % | 33.48 % | 27.08 % | 23.85 % | 22.62 % | 21.66 % | 11.86 % | 19.64 % | 18.72 % | 18.46 % |
| DIIs | 7.81 % | 8.73 % | 7.78 % | 7.87 % | 8.12 % | 9.62 % | 8.94 % | 8.93 % | 8.94 % | 8.56 % | 7.64 % | 7.15 % | 13.70 % | 16.35 % | 20.91 % | 22.91 % | 24.59 % | 24.09 % | 25.28 % | 26.32 % | 26.12 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 3.70 % | 4.44 % | 4.21 % | 4.33 % | 3.92 % | 3.70 % | 3.43 % | 3.34 % | 3.18 % | 3.39 % | 3.15 % | 2.96 % | 3.09 % | 6.98 % | 5.94 % | 5.04 % | 4.38 % | 4.12 % | 3.94 % | 3.86 % | 4.07 % |
| Others | 50.61 % | 48.94 % | 50.12 % | 49.92 % | 50.08 % | 48.80 % | 49.75 % | 16.76 % | 16.92 % | 17.08 % | 7.11 % | 18.93 % | 7.85 % | 7.72 % | 7.42 % | 7.55 % | 7.49 % | 19.56 % | 10.76 % | 10.70 % | 10.95 % |
| No of Share Holders | 0 | 78,719 | 93,506 | 87,804 | 80,746 | 80,427 | 78,374 | 80,913 | 82,129 | 71,379 | 67,673 | 67,331 | 80,931 | 2,06,660 | 1,74,171 | 1,59,038 | 1,54,014 | 1,51,664 | 1,48,139 | 1,47,304 | 1,46,998 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 120 | 5 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.82 | 0.75 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 31 Aug 2023 |  Annual General Meeting | NA | 31 Aug 2023 | 312.45 | 331.20 |
| 23 Apr 2024 |  Dividend | ₹ 118.00 /share | 23 Apr 2024 | 475.25 | 513.35 |
| 22 Aug 2024 | Dividend | ₹ 2.00 /share | 22 Aug 2024 | 375.20 | 401.15 |
| 29 Aug 2024 | Annual General Meeting | NA | 29 Aug 2024 | 379.30 | 409.90 |
| 23 Oct 2024 |  Quarterly Result Announcement | NA | 23 Oct 2024 | 427.95 | 405.20 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 494.65 | 485.30 |
| 10 Feb 2025 | Dividend | ₹ 4.00 /share | 10 Feb 2025 | 485.30 | 473.20 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 550.10 | 584.15 |
| 30 Jul 2025 | Quarterly Result Announcement | NA | 30 Jul 2025 | 595.05 | 590.95 |
| 28 Aug 2025 | Dividend | ₹ 1.00 /share | 28 Aug 2025 | 584.15 | 601.00 |
| 04 Sept 2025 | Annual General Meeting | NA | 04 Sept 2025 | 590.95 | 620.00 |
| 06 Nov 2025 | Quarterly Result Announcement | NA | 06 Nov 2025 | 697.60 | 688.70 |
| 30 Jan 2026 | Quarterly Result Announcement | NA | 30 Jan 2026 | 576.00 | 539.15 |
| 10 Mar 2026 |  Extraordinary General Meeting | NA | 10 Mar 2026 | 546.50 | 658.30 |
| 03 Apr 2026 | Dividend | ₹ 3.00 /share | 02 Apr 2026 | 652.00 | 658.10 |
Announcements
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
6 days ago
6 days agoShareholder Meeting / Postal Ballot-Outcome of Postal_Ballot6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release9 days ago
9 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Apr 07, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 02, 2026
Apr 02, 2026Communication To ShareholdersMar 27, 2026
Mar 27, 2026Corporate Action-Board approves DividendMar 26, 2026
Mar 26, 2026Board Meeting Outcome for Declared Interim Dividend For FY 2025-26Mar 26, 2026
Mar 26, 2026Announcement Under Regulation 30 Of SEBI (LODR) RegulationsMar 25, 2026
Mar 25, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 23, 2026
Mar 23, 2026Board Meeting Intimation for Declaration Of Interim Dividend For FY 2025-26Mar 20, 2026
Mar 20, 2026Closure of Trading WindowMar 19, 2026
Mar 19, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 14, 2026
Mar 14, 2026Announcement under Regulation 30 (LODR)-Strikes /Lockouts / DisturbancesMar 14, 2026
Mar 14, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 13, 2026
Mar 13, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 11, 2026
Mar 11, 2026Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 11, 2026
Mar 11, 2026Unsecured Creditors Meeting - Scrutinizers Report And E-Voting ResultsMar 11, 2026
Mar 11, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateMar 10, 2026
Mar 10, 2026Proceedings Of The Meeting Of Unsecured Trade CreditorsMar 10, 2026
Mar 10, 2026Shareholder Meeting / Postal Ballot-Outcome of Court Convened MeetingMar 10, 2026
Mar 10, 2026Announcement Under Regulation 30 (LODR)Mar 02, 2026
Mar 02, 2026Announcement Under Regulation 30 Of SEBI (LODR)Feb 26, 2026
Feb 26, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 20, 2026
Feb 20, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2026
Feb 10, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2026
Feb 10, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 09, 2026
Feb 09, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 05, 2026
Feb 05, 2026Notice Of Meeting Of The Unsecured Creditors Of Aster DM Healthcare Limited To Be Convened As Per The Directions Provided In The Order Of The Honble NCLT HyderabadFeb 04, 2026
Feb 04, 2026Notice Of Meeting Of The Equity Shareholders Of Aster DM Healthcare Limited To Be Convened As Per The Directions Provided In The Order Of The Honble NCLT HyderabadFeb 04, 2026
Feb 04, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 02, 2026
Feb 02, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 02, 2026
Feb 02, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2026
Jan 31, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJan 30, 2026
Jan 30, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 30, 2026
Jan 30, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 30, 2026
Jan 30, 2026UpdatesJan 30, 2026
Jan 30, 2026Announcement under Regulation 30 (LODR)-AcquisitionJan 30, 2026
Jan 30, 2026Board Meeting Outcome for Outcome Of Board MeetingJan 30, 2026
Jan 30, 2026Announcement under Regulation 30 (LODR)-AcquisitionJan 29, 2026
Jan 29, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 27, 2026
Jan 27, 2026Board Meeting Intimation for Approving Unaudited Financial Results For The Quarter Ended December 31 2025Jan 23, 2026
Jan 23, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 23, 2026
Jan 23, 2026Receipt Of NCLT Order Dated January 21 2026Jan 22, 2026
Jan 22, 2026Monthly Report On Special Window Re-Lodgement Of SharesJan 07, 2026
Jan 07, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 03, 2026
Jan 03, 2026Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 55.47
ATR(14)
Less Volatile 22.20
STOCH(9,6)
Neutral 64.74
STOCH RSI(14)
Neutral 41.74
MACD(12,26)
Bullish 0.25
ADX(14)
Weak Trend 19.30
UO(9)
Bearish 48.79
ROC(12)
Downtrend And Accelerating -1.18
WillR(14)
Neutral -46.68
About Aster DM Healthcare
Aster DM Healthcare is a healthcare service provider operating in the GCC and India. Founded in 1987 by Dr. Azad Moopen, the company offers a range of healthcare services through a network of hospitals, clinics, pharmacies, and labs. As of March 2023, Aster DM Healthcare operates 32 hospitals, 127 clinics,...more
Listing Date
26 Feb, 2018(8 Years,
-4 days)
Chairperson NameMandayapurath Azad Moopen
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
